SCALERA, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 136
AS - Asia 38
EU - Europa 28
AF - Africa 3
Totale 205
Nazione #
US - Stati Uniti d'America 132
SG - Singapore 21
CN - Cina 17
IT - Italia 10
IE - Irlanda 7
NL - Olanda 6
FI - Finlandia 5
CA - Canada 4
CI - Costa d'Avorio 3
Totale 205
Città #
Chandler 37
Singapore 18
Ashburn 8
Des Moines 7
Naples 7
Amsterdam 6
Beijing 6
Princeton 6
Millbury 5
Dallas 4
Fort Worth 4
Ottawa 4
Boston 3
Jiaxing 3
Hebei 2
Boardman 1
Cheyenne 1
Dublin 1
Fairfield 1
Florence 1
Lawrence 1
Little Rock 1
Nanchang 1
Nanjing 1
New York 1
Redwood City 1
Shenyang 1
Taizhou 1
Tianjin 1
Totale 134
Nome #
Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: A meta-analysis of randomized controlled trials 41
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 37
Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research 36
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? 27
Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis 25
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 23
Liver-spleen axis: Intersection between immunity, infections and metabolism 23
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 12
Totale 224
Categoria #
all - tutte 1.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.295


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 7 3
2020/20213 0 0 1 0 1 1 0 0 0 0 0 0
2021/202236 0 0 0 1 0 2 0 0 6 3 9 15
2022/202371 7 2 0 9 9 13 0 10 11 7 2 1
2023/202435 2 7 5 4 4 1 0 3 0 0 8 1
2024/202530 6 19 0 0 5 0 0 0 0 0 0 0
Totale 224